Le Lézard
Classified in: Health
Subjects: CSR, PET, ANW

People, Pets & Vets: Unleashed in the Community


OLYMPIA, Wash., April 7, 2022 /PRNewswire/ -- The teams at People, Pets & Vets (PPV) local animal hospitals love serving the pets in their community through compassionate care and top-quality medicine. Unleashed in the Community is an initiative that celebrates the good that our family of hospitals are doing to help even more pets in their local communities.

Their animal-loving team members are making an impact in their neighborhoods by partnering with local organizations, hosting pet supply drives, and volunteering at local animal shelters. They know that even the smallest efforts can make the biggest impact, and we are here to support, encourage and celebrate their dedication.

PPV is truly inspired by our hospitals' philanthropy and is proud to introduce Bravado's Campaign, a fund that supports organizations on a larger scale in the veterinary industry. PPV founder, Dr. Michael Murphy, had a childhood golden retriever named Bravado.  He shaped his life and led to him choosing a career in veterinary medicine. While veterinary school can dive deep into the medicine, Bravado was the constant reminder of his "why" behind this profession - to strengthen and nurture the human-animal bond.

Dr. Murphy, shared "We are so honored and feel so fortunate that People, Pets & Vets recently donated $50,000 to the American Veterinary Medical Fund to help their cause of rescuing the stranded pets in Ukraine. Due to the political unrest and citizens fleeing the country, millions of animals have been forced to fend for themselves, no longer receiving the care they need."

With over 130 hospitals in the family, PPV is excited that their family has expanded and even more thrilled to celebrate their local altruistic endeavors! To read the awesome stories about PPV and their impact on their communities, please visit peoplepetsandvets.com/unleashed. Check back often because these heartwarming stories keep coming in.

People, Pets and Vets, born in 1992, is a veterinarian-led group with animal hospitals located throughout the western and southern United States. Each hospital provides a range of general and surgical services while making a positive impact in their communities. PPV offers a compelling opportunity to veterinarians looking to sell their practice and career opportunities to veterinarians and support staff. By creating a network of passionate professionals who work smarter, PPV has a strong track record of treating people well, always doing what they say, and creating a relationship built on trust.

Contact: [email protected]

SOURCE People, Pets & Vets


These press releases may also interest you

at 01:05
Vifor Fresenius Medical Care Renal Pharma (VFMCRP) and Cara Therapeutics, Inc. today announced that they have received approval for Kapruvia® from the Swiss Agency for Therapeutic Products (Swissmedic). Kapruvia® will be the first therapy available...

at 01:00
The latest market analysis report titled Intraoral Scanners Market by End-user and Geography - Forecast and Analysis 2021-2025 has been added to Technavio's catalog. The report predicts the market to witness an accelerating growth momentum at a CAGR...

at 01:00
Angel Yeast, (SH600298), a globally listed yeast and yeast extract manufacturer, showcased its latest yeast and yeast extract products, health ingredients, and fermentation ingredients alongside its wide range of innovative solutions at FIC 2022 in...

18 aoû 2022
Nuance Pharma ("the Company") announces the Center for Drug Evaluation ("CDE") has approved its Investigational New Drug ("IND") application supporting its pivotal clinical trial of Ensifentrine for the maintenance treatment of chronic obstructive...

18 aoû 2022
Celltrion Healthcare announced today that the European Commission (EC) has approved Vegzelmatm (CT-P16), a biosimilar bevacizumab referencing EU-approved Avastin®, for the treatment of metastatic breast cancer, non-small cell lung cancer, advanced...

18 aoû 2022
Jiangsu Recbio Technology Co., Ltd. (the "Company", together with its subsidiaries, the "Group") is pleased to announce that, the Company has completed the subject enrollment and dosing for the comparative Phase II clinical trial between its...



News published on 7 april 2022 at 14:37 and distributed by: